CHRONIC SUPPRESSIVE THYROXINE THERAPY AND FOREARM, SPINAL AND HOP BONE-DENSITY IN 114 PATIENTS WITH THYROID-CANCER

被引:0
|
作者
HAWKINS, F
LOPEZ, MB
RIGOPOULOU, D
PAPAPIETRO, K
GARCIA, L
SARABIA, F
ARNAIZ, F
机构
[1] UNIV MADRID,HOSP 12 OCTUBRE,SERV ENDOCRINOL,MADRID 3,SPAIN
[2] UNIV MADRID,HOSP 12 OCTUBRE,SERV NUCL MED,MADRID 3,SPAIN
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S252 / S252
页数:1
相关论文
共 44 条
  • [1] BONE-DENSITY AND THYROID-HORMONE SUPPRESSIVE THERAPY FOR THYROID-CARCINOMA
    EULRY, F
    BAUDUCEAU, B
    LECHEVALIER, D
    MAGNIN, J
    CROZES, P
    FLAGEAT, J
    GAUTIER, D
    [J]. REVUE DU RHUMATISME, 1992, 59 (04): : 247 - 252
  • [2] REDUCING SUPPRESSIVE THERAPY IN PATIENTS WITH A HISTORY OF THYROID-CANCER
    BLUM, M
    PERLMAN, S
    [J]. ANNALS OF INTERNAL MEDICINE, 1995, 123 (10) : 808 - 809
  • [3] Markers of bone turnover in patients with differentiated thyroid cancer with and following withdrawal of thyroxine suppressive therapy
    Toivonen, J
    Tahtela, R
    Laitinen, K
    Risteli, J
    Valimaki, MJ
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1998, 138 (06) : 667 - 673
  • [4] Bone mineral density in women receiving thyroxine suppressive therapy for differentiated thyroid carcinoma
    Chen, CH
    Chen, JF
    Yang, BY
    Liu, RT
    Tung, SC
    Chien, WY
    Lu, YC
    Kuo, MC
    Hsieh, CJ
    Wang, PW
    [J]. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2004, 103 (06) : 442 - 447
  • [5] Bone mineral density in patients receiving suppressive doses of thyroxine for differentiated thyroid carcinoma
    Gorres, G
    Kaim, A
    Otte, A
    Gotze, M
    MullerBrand, J
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1996, 23 (06): : 690 - 692
  • [6] Change of bone mineral density and biochemical markers of bone turnover in patients on suppressive L-thyroxine therapy for differentiated thyroid carcinoma
    Hong, S.
    Park, W.
    Kim, S.
    Nam, M.
    Kim, Y.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S315 - S315
  • [7] BONE-MINERAL DENSITY IN PATIENTS RECEIVING SUPPRESSIVE DOSES OF THYROXINE FOR THYROID-CARCINOMA
    FLORKOWSKI, CM
    BROWNLIE, BEW
    ELLIOT, JR
    AYLING, EM
    TURNER, JG
    [J]. NEW ZEALAND MEDICAL JOURNAL, 1993, 106 (966) : 443 - 444
  • [8] Bone mineral density in well-differentiated thyroid cancer patients treated with suppressive thyroxine: A systematic overview of the literature
    Quan, ML
    Pasieka, JL
    Rorstad, O
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2002, 79 (01) : 62 - 69
  • [9] SPINAL BONE MASS AFTER LONG-TERM TREATMENT WITH L-THYROXINE IN POSTMENOPAUSAL WOMEN WITH THYROID-CANCER AND CHRONIC LYMPHOCYTIC THYROIDITIS
    HAWKINS, F
    RIGOPOULOU, D
    PAPAPIETRO, K
    LOPEZ, MB
    [J]. CALCIFIED TISSUE INTERNATIONAL, 1994, 54 (01) : 16 - 19
  • [10] Bone mineral density in well-differentiated thyroid cancer patients treated with suppressive thyroxine: A systematic overview of the literature - Commentary
    Hoff, AO
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2002, 79 (01) : 69 - 70